Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Turriziani

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|February 24, 2001
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2I Abbate, F Dianzani, O Turriziani, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Interferon-induced gene expression in cervical mucosa during human papillomavirus infectionA Pierangeli, A M Degener, M L Ferreri, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 29, 1999
Synthesis and HIV-1 inhibitory properties of new tetrahydrobenzoquinazolinedione and tetrahydrobenzocycloheptenuracil derivatives and of their thioxo analoguesM Macchia, G Antonelli, A Balsamo, et al.
Journal of Medical Virology|August 21, 2014
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapyI Bon, O Turriziani, G Musumeci, et al.
Journal of Endocrinological Investigation|October 11, 2020
Sperm cryopreservation during the SARS-CoV-2 pandemicD Paoli, F Pallotti, G Nigro, et al.
Journal of the Neurological Sciences|October 20, 1999
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.
Infection|September 26, 2012
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesisM Cagliuso, V Conti, S Trasarti, et al.
The New Microbiologica|January 14, 2005
P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell lineA Maffeo, F Bellomi, I Solimeo, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.
Infection|October 19, 2014
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patientsF Falasca, P Maida, A Gaeta, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|February 24, 2001
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2I Abbate, F Dianzani, O Turriziani, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Interferon-induced gene expression in cervical mucosa during human papillomavirus infectionA Pierangeli, A M Degener, M L Ferreri, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 29, 1999
Synthesis and HIV-1 inhibitory properties of new tetrahydrobenzoquinazolinedione and tetrahydrobenzocycloheptenuracil derivatives and of their thioxo analoguesM Macchia, G Antonelli, A Balsamo, et al.
Journal of Medical Virology|August 21, 2014
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapyI Bon, O Turriziani, G Musumeci, et al.
Journal of Endocrinological Investigation|October 11, 2020
Sperm cryopreservation during the SARS-CoV-2 pandemicD Paoli, F Pallotti, G Nigro, et al.
Journal of the Neurological Sciences|October 20, 1999
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.
Infection|September 26, 2012
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesisM Cagliuso, V Conti, S Trasarti, et al.
The New Microbiologica|January 14, 2005
P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell lineA Maffeo, F Bellomi, I Solimeo, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.
Infection|October 19, 2014
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patientsF Falasca, P Maida, A Gaeta, et al.
Pageof 5